Staquis

Staquis

crisaborole

Manufacturer:

Pfizer

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Crisaborole
Indications/Uses
Mild to moderate atopic dermatitis in patients ≥3 mth.
Dosage/Direction for Use
Adult, adolescent & childn 3 mth to 17 yr Apply bid to affected areas including face, neck, & intertriginous areas.
Contraindications
Special Precautions
Not for oral, ophth, or intravag use. Discontinue treatment immediately if signs & symptoms of hypersensitivity including contact urticaria (eg, severe pruritus, swelling & erythema at application or distant site) occur. Thoroughly wipe off &/or rinse w/ water in cases of accidental exposure to mouth, eyes or vagina. Pregnancy & lactation. Not to be applied to the breast to avoid unintentional ingestion by newborn.
Adverse Reactions
Application site reactions eg, pain (burning or stinging) & pruritus.
Drug Interactions
Moderate increased conc of sensitive UGT1A9 substrates.
MIMS Class
Other Dermatologicals
ATC Classification
D11AH06 - crisaborole ; Belongs to the class of agents for atopic dermatitis, excluding corticosteroids. Used in the treatment of atopic dermatitis.
Presentation/Packing
Form
Staquis oint 2% w/w
Packing/Price
2.5 g x 1's;30 g x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in